200 related articles for article (PubMed ID: 30265643)
41. Partial warfarin reversal prior to hip fracture surgical intervention in geriatric trauma patients effects on blood loss and transfusions.
Meinig R; Cornutt D; Jarvis S; Salottolo K; Kelly M; Harrison P; Nentwig M; Morgan S; Nwafo N; McNair P; Banerjee R; Woods B; Bar-Or D
J Clin Orthop Trauma; 2021 Mar; 14():45-51. PubMed ID: 33717896
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage.
Siddiq F; Jalil A; McDaniel C; Brock DG; Pineda CC; Bell RD; Lee K
Neurocrit Care; 2008; 8(1):36-41. PubMed ID: 17898941
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
44. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
[TBL] [Abstract][Full Text] [Related]
45. Prothrombin complex concentrate (PCC, Octaplex) in patients requiring immediate reversal of vitamin K antagonist anticoagulation.
Song MM; Warne CP; Crowther MA
Thromb Res; 2012 Apr; 129(4):526-9. PubMed ID: 22304928
[No Abstract] [Full Text] [Related]
46. Anticoagulation management in hip fracture patients on warfarin.
Al-Rashid M; Parker MJ
Injury; 2005 Nov; 36(11):1311-5. PubMed ID: 16214475
[TBL] [Abstract][Full Text] [Related]
47. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
[TBL] [Abstract][Full Text] [Related]
48. Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals.
Santibanez M; Lesch CA; Lin L; Berger K
J Crit Care; 2018 Dec; 48():183-190. PubMed ID: 30218958
[TBL] [Abstract][Full Text] [Related]
49. Less Is More: Low-dose Prothrombin Complex Concentrate Effective in Acute Care Surgery Patients.
Quick JA; Meyer JM; Coughenour JP; Barnes SL
Am Surg; 2015 Jun; 81(6):646-50. PubMed ID: 26031281
[TBL] [Abstract][Full Text] [Related]
50. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.
Leissinger CA; Blatt PM; Hoots WK; Ewenstein B
Am J Hematol; 2008 Feb; 83(2):137-43. PubMed ID: 17729241
[TBL] [Abstract][Full Text] [Related]
51. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
[TBL] [Abstract][Full Text] [Related]
52. Dose-associated pulmonary complication rates after fresh frozen plasma administration for warfarin reversal.
Marshall AL; Levine M; Howell ML; Chang Y; Riklin E; Parry BA; Callahan RT; Okechukwu I; Ayres AM; Nahed BV; Goldstein JN
J Thromb Haemost; 2016 Feb; 14(2):324-30. PubMed ID: 26644327
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
[TBL] [Abstract][Full Text] [Related]
54. Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.
Yin EB; Tan B; Nguyen T; Salazar M; Putney K; Gupta P; Suarez JI; Bershad EM
Neurocrit Care; 2017 Aug; 27(1):51-59. PubMed ID: 28243997
[TBL] [Abstract][Full Text] [Related]
55. Use of prothrombin complex concentrate as an adjunct to fresh frozen plasma shortens time to craniotomy in traumatic brain injury patients.
Joseph B; Pandit V; Khalil M; Kulvatunyou N; Aziz H; Tang A; OʼKeeffe T; Hays D; Gries L; Lemole M; Friese RS; Rhee P
Neurosurgery; 2015 May; 76(5):601-7; discussion 607. PubMed ID: 25886249
[TBL] [Abstract][Full Text] [Related]
56. The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin.
Varga C; Al-Touri S; Papadoukakis S; Caplan S; Kahn S; Blostein M
Transfusion; 2013 Jul; 53(7):1451-8; quiz 1450. PubMed ID: 23067393
[TBL] [Abstract][Full Text] [Related]
57. Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy.
Junagade P; Grace R; Gover P
Hematology; 2007 Oct; 12(5):439-40. PubMed ID: 17852462
[TBL] [Abstract][Full Text] [Related]
58. Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants?
Mangram A; Oguntodu OF; Dzandu JK; Hollingworth AK; Hall S; Cung C; Rodriguez J; Yusupov I; Barletta JF
J Crit Care; 2016 Jun; 33():252-6. PubMed ID: 27021851
[TBL] [Abstract][Full Text] [Related]
59. Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol.
Wozniak M; Kruit A; Padmore R; Giulivi A; Bormanis J
Transfus Apher Sci; 2012 Jun; 46(3):309-14. PubMed ID: 22503307
[TBL] [Abstract][Full Text] [Related]
60. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
